Convergent Dental Appoints David Garabedian As Vice President Of Marketing

BOSTON--(BUSINESS WIRE)--Convergent Dental, Inc., a privately held dental device company, today announced that David Garabedian has joined the team as Vice President of Marketing. In this role, Mr. Garabedian will own all aspects of marketing for Convergent Dental's flagship product Solea®, the first FDA cleared CO2 9.3 micron dental laser for hard, soft and osseous tissue procedures. In addition he will drive the company's many upcoming innovations from concept to commercialization.

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

U.K.-based alpha-synuclein biotech Wren will partner with Japanese pharma Eisai to seek out new ways of targeting neuro disorders.

As Moderna continues to drip-feed the latest data from its late-stage COVID-19 vaccine effort, it has updated the shot’s efficacy figure.

Two research teams have discovered drug combinations that may make it possible to translate CAR-T cell therapies to solid tumors.